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Hemiplegic migraine occurs both sporadically and as a familial syndrome. Familial 
hemiplegic migraine (FHM) is defined by migraine with aura and motor weakness 
and at least one first- or second-degree relative with migraine aura and motor 
weakness on one side of the body as a symptom. Sporadic hemiplegic migraine has 
the same clinical features as FHM, but with no family history of motor weakness 
(1).The ICHD-3 (beta version) diagnostic criteria for migraine with aura were 
changed during the 2004 and the 2013 editions. Now all attacks that meet criteria 
for migraines and include reversible weakness (motor aura) that last from 5 minutes 
to 72 h should be coded as hemiplegic migraine (familial or sporadic) once other 
causes, such as transient ischemic attack and stroke, have been excluded (2). In some 
patients, motor weakness may last weeks. Each individual non-motor aura symptom 
lasts 5–60 minutes and the aura is accompanied, or followed within 60minutes, by 
headache(2).Rarely, during FHM attacks, disturbances of consciousness(sometimes 
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Objective 
Familial hemiplegic migraine (FHM) is an autosomal dominantly inherited 
subtype of migraine with aura, characterized by transient neurological signs 
and symptoms. Typical hemiplegic migraine attacks start in the first or second 
decade of life. Some patients with FHM suffer from daily recurrent attacks since 
childhood. Results from extensive studies of cellular and animal models have 
indicated that gene mutations in FHM increase neuronal excitability and reduce 
the threshold for spreading depression (SD). SD is a transient wave of profound 
neuronal and glial depolarization that slowly propagates throughout the brain 
tissue and is characterized by a high amplitude negative DC shift. After induction 
of SD, S218L mutant mice exhibited neurological signs highly reminiscent of 
clinical attacks in FHM type 1 patients carrying this mutation. FHM1 with 
ataxia is attributable to specific mutations that differ from mutations that cause 
pure FHM1 and have peculiar consequences on cerebellar Cav2.1 currents that 
lead to profound Purkinje cell dysfunction and neuronal loss with atrophy. SD 
in juvenile rats produced neuronal injury and death. Hormonal factors involved 
in FHM affect SD initiation and propagation. The data identify SD as a possible 
target of treatment of FHM. In addition, FHM is a useful model to explore the 
mechanisms of more common types of migraine.
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responsible for 50%–70% of published families with 
FHM.FHM is classified into FHM-1, FHM-2, and 
FHM-3, depending on specific genetic mutations. New 
genetic data have allowed for more precise data on FHM 
than was previously available. Specific genetic subtypes 
have been characterized as follows: 1. in FHM1 there are 
mutations in the CACNA1A gene (e.g., R192Q, S218L; 
coding for pore-forming α1A subunit of neuronal 
voltage-gated CaV2.1 channels)on chromosome 19p13; 
2. in FHM2 there are mutations in the ATP1A2 gene 
(coding for a K/Na-ATPase) on chromosome 1q23; and 
3. in FHM3 there are mutations in the SCN1A gene 
(coding for a sodium channel)on chromosome 2q24 
(16). Mutations in ATP1A2 are associated with a rare 
form of hereditary FHM type 2 in some patients (17). 
There may be other loci not yet identified. Patients 
with type 1 mutations, which account for almost 50% 
of all FHM cases, have a 90% chance of experiencing 
a loss of motor function during a hemiplegic headache 
attack.FHM type 2 and type 3 mutations are much less 
common and are associated with recurrent seizures 
(18, 19).In experimental studies, FHM1 mutations 
shift calcium channel opening toward more negative 
membrane potentials and delay channel inactivation. 
Calcium channels open with smaller depolarization and 
stay open longer (20), presumably allowing more Ca2+ 
to enter presynaptic terminals that result in increased 
glutamate release to the extracellular compartment. 
This may be the mechanism of cortical and subcortical 
hyper excitability in patients suffering from FHM. It was 
suggested that altered P/Q-type calcium channel gating 
represents a common pathophysiological mechanism 
in approximately one-half of families. The same gene 
is also involved in the common forms of migraine with 
and without aura (21). A recent study showed that sibling 
pairs with any form of migraine, especially migraine 
with aura, had inherited the same 19p13 CACNA1A 
(22). The complex cellular and molecular environment in 
FHM could support a new tissue phenotype compatible 
with a neuroinflammatory profile. In patients with 
FHM, this condition might contribute to trigeminal pain 
pathophysiology through release of soluble mediators, 
including TNFα and may modulate the crosstalk between 
sensory neurons and resident glia, which is underlying 
the process of neuronal sensitization (23). Chemokine 
including coma), confusion, fever, and cerebrospinal 
fluid pleocytosis may occur.FHM attacks can be triggered 
by (mild to moderate) head trauma. In approximately 
50% of FHM families, chronic progressive cerebellar 
ataxia occurs independently of migraine attacks. More 
than 60% of FHM patients also suffer from migraine 
attacks with typical aura or without aura, making FHM a 
useful genetic model to explore the mechanisms of more 
common types of migraine as well (3, 4).
FHM may be mistaken for epilepsy (postictal paresis, 
Jacksonian march, or Todd paralysis) and unsuccessfully 
treated. The duration of the gradual progression of the 
aura symptoms in FHM is 60 min on average, which is 
never seen in epilepsy, and that visual symptoms usually 
accompany paresis, which almost never happens in 
epilepsy (3).Inherited disorders associated with migraine 
headaches may include hemipares is such as CADASIL 
(5), MELAS (6), hereditary hemorrhagic telangiectasia 
(7), a form of hereditary amyloid angiopathy (8), familial 
cerebral cavernous malformation (9), and benign 
familial infantile convulsions (10).Magnetic resonance 
angiography revealed subtle narrowing of the left 
middle cerebral artery. The neuroimaging abnormalities 
completely resolved 24 h after attack onset. Multiple 
conventional and advanced MRI techniques play a key 
role in an FHM attack to exclude acute arterial ischemic 
stroke (11).
On average 50% of children who have a parent with 
hemiplegic migraine will develop this disorder. The 
estimated prevalence of hemiplegic migraine is 0.01% (in 
the Danish population). Sporadic hemiplegic migraine 
and familial hemiplegic migraine have occurred with 
approximate equal prevalence. Hemiplegic attacks in 
familial hemiplegic migraine may begin as early as 5 to 
7 years of age, with a mean age of onset of 12 years 
(range 1 to 51 years) in one study and 17 years (range 1 
to 45 years) in another study (12, 13). Some patients with 
FHM have suffered from daily recurrent attacks since 
childhood (14). Hemiplegic migraine patients often stop 
experiencing attacks after the age of 50. Female-to-male 
gender ratios for hemiplegic migraine ranges from 2.5:1 
to 4.3:1 (12, 15).Like other types of migraines, FHM 
affects women more than men.
FHM is an autosomal dominant, genetically 
heterogeneous disorder. Mutations in 3 genes are 
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modulates neuronal activity and synaptic plasticity 
in neuronal tissue and may be involved in clinical 
symptoms such as headache and seizure attacks (24).
The role of spreading depression (SD) in FHM
SD is widely viewed as the electrophysiological 
event underlying migraine aura, and an intense self-
propagating front of neuroglial depolarization wave that 
spreads (2-3 mm/min) by way of gray matter contiguity, 
regardless of functional divisions (25). Underlying SD 
is a dramatic change in the distribution of ions between 
extra- and intracellular micromilieu. K+ and H+ release 
from the cells, while Na+, Ca2+ and Cl− enter together 
with water to the neurons causing cells to swell and the 
volume of the extracellular compartment to be reduced. 
SD is accompanied by an increase of glucose utilization 
and O2 consumption. Recovery of SD depends on 
energy metabolism (26, 27).
A brief period of neuronal excitation heralds SD, 
which is immediately followed by a prolonged nerve 
cell depression. A late excitatory period following the 
depression phase of SD occurred. It has been shown that 
induction of SD initially suppresses synaptic activity, 
which is followed by an irreversible potentiation of 
synaptic plasticity in human neocortical tissues obtained 
during epilepsy surgery(28, 29). Several investigations 
have also demonstrated a late excitable state of neuronal 
activities in various different brain structures remote 
from SD. Propagation of cortical spreading depression 
(CSD) is accompanied by the release and diffusion of 
several chemical mediators, such as excitatory amino 
acids, neurokinin, calcitonin gene-related peptide, 
serotonin, and brain-derived neurotrophic factors into 
the extracellular space, which may change the neuronal 
network excitability (26, 27).
SD belongs to the pathophysiology of the brain and 
there are reasons to believe that it is involved in 
several neurological disorders, including migraine with 
aura, cerebrovascular diseases (stroke, subarachnoid 
hemorrhage, intracerebral hemorrhage), head injury, 
epilepsy, and transient global amnesia (26, 30). 
Available evidence strongly suggests involvement 
of SD in the pathophysiology of FHM type1. As 
mentioned, FHM type 1 is linked to chromosome 19p13 
and mutations in the calcium channel α1A-subunit, 
CACNA1A, as well as to an altered P/Q-type calcium 
channel gating. Experiments on mutant mice provide 
mechanistic insight into modulation of SD susceptibility 
as a relevant mechanism in FHM. Mutations in the α1A-
subunit of P/Q type calcium channels in mice attenuate 
evoked extracellular glutamate levels and increased the 
threshold for SD (20).The tottering mutation (a proline-
to-leucine substitution in the S5-S6 linker region of 
the α1 subunit of the P/Q-type Ca2+ channel) causes 
loss-of-channel function, impaired presynaptic Ca2+ 
influx, and decreased neurotransmitter release that 
mainly inhibits excitatory neurotransmission (20, 31). 
Tottering mice show a ten-fold resistance to SD, with a 
slower SD propagation velocity and a failure to sustain 
regenerative propagation of the depolarization potential 
(32). Although these results indicate that mutations 
increased the SD threshold and are not consistent with 
the SD causative role in aura, they do reveal linkage 
between mutant P/Q type Ca2+ channels and SD (26).
In contrast to this study, mutant mouse models 
expressing human FHM type 1 mutations in the same 
gene (R192Q or S218L) exhibit increased susceptibility 
to SD in the neocortex and the transient hemiplegia 
in response to SD initiation(20, 33, 34). The S218L 
variant exhibits larger gain-of-function (in vitro) and 
higher SD susceptibility (in vivo) in comparison to the 
R192Q mutation (33, 34). In contrast to pure hemiplegic 
migraine associated with the R192Q mutation, attacks 
in patients carrying the S218L mutation are sometimes 
accompanied by disturbances of consciousness, such 
as coma or stupor, and generalized seizures (18). 
Accordingly, neocortical SD induced pure hemiplegia 
in R192Q mutant mice, whereas S218L mutants 
additionally developed coma and often severe seizure 
attacks (33, 34).In addition, FHM type 1 mutant mice 
showed a facilitated subcortical propagation of cortical 
SD, which provide sa potential explanation for the 
hemiplegia, seizures, and coma in FHM patients(35).
Further data suggest that sex hormones in addition 
to genetic factors modulate SD susceptibility in the 
animal model of FHM. Consistent with the female 
preponderance of FHM, female mice expressing the 
R192Q or S218L mutation showed a higher susceptibility 
than male mice toward SD (36). It has been shown that 
both estrogen and progesterone facilitate occurrence of 
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the severity and duration of neurological deficit in FHM 
(46).Experimental models of CSD as a surrogate for aura 
can be useful in preclinical drug screening for migraine 
eprophylaxis, including FHM, as well as for improving 
our knowledge of its basic mechanisms (47-50).
In conclusion, SD seems to play a crucial role in 
pathophysiology of FHM. Both genetic and hormonal 
factors in FHM affect SD initiation and propagation, 
and SD mimics symptom in animal models of FHM. 
Therefore, SD may be a potential target for prevention of 
migraine attacks in FHM. Furthermore, FHM is a useful 
model to explore the mechanisms of more common 
types of migraine.
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